Boston Scientific Corp. (BSX) Misses Q2 EPS by 1c

Boston Scientific Corp. (NYSE: BSX) reported Q2 EPS of $0.18, $0.01 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $1.87 billion versus the consensus estimate of $1.87 billion.

For earnings history and earnings-related data on Boston Scientific Corp. (BSX) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Azitra, Inc. (AZTR) Tops Q2 EPS by 54c
• Brinker Int'l (EAT) PT Raised to $285 at UBS Following 'Impressive' Q4 Outperformance